Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of Skin Cancer
Jinyuan Ma,Zongguang Tai,Ying Li,Yang Li,Jiandong Wang,Tao Zhou,Min Shen,Rujuan Xin,Cuie Shen,Quangang Zhu,Zhongjian Chen
DOI: https://doi.org/10.2147/ijn.s443835
IF: 7.033
2024-03-05
International Journal of Nanomedicine
Abstract:Jinyuan Ma, 1, 2, &ast Zongguang Tai, 1, 2, &ast Ying Li, 1, 2, &ast Yang Li, 3 Jiandong Wang, 1, 2 Tao Zhou, 1, 2 Min Shen, 1, 2 Rujuan Xin, 1, 2 Cuie Shen, 1, 2 Quangang Zhu, 1, 2 Zhongjian Chen 1, 2 1 Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China; 2 Shanghai Engineering Research Center for Topical Chinese Medicine, Shanghai, People's Republic of China; 3 CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Quangang Zhu; Zhongjian Chen, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai, 200443, People's Republic of China, Tel/Fax +86 21 36803155 ; +86 21 36803007, Email ; Purpose: Photodynamic therapy (PDT) has been an attractive strategy for skin tumor treatment. However, the hypoxic microenvironment of solid tumors and further O 2 consumption during PDT would diminish its therapeutic effect. Herein, we developed a strategy using the combination of PDT and hypoxia-activated bioreductive drug tirapazamine (TPZ). Methods: TPZ was linked to DSPE-PEG-NHS forming DSPE-PEG-TPZ to solve leakage of water-soluble TPZ and serve as an antitumor agent and monomer molecule further forming the micellar. Chlorin e6 (Ce6) was loaded in DSPE-PEG-TPZ forming DSPE-PEG-TPZ@Ce6 (DPTC). To further improve tumor infiltration and accumulation, hyaluronic acid was adopted to make DPTC-containing microneedles (DPTC-MNs). Results: Both in vitro and in vivo studies consistently demonstrated the synergistic antitumor effect of photodynamic therapy and TPZ achieved by DPTC-MNs. With laser irradiation, overexpressions of PDT tolerance factors NQO1 and HIF-1α were inhibited by this PDT process. Conclusion: The synergistic effect of PDT and TPZ significantly improved the performance of DPTC-MNs in the treatment of melanoma and cutaneous squamous cell carcinoma and has good biocompatibility. Keywords: photodynamic therapy, hypoxia activation, combination therapy, PDT enhancement Photodynamic therapy (PDT) has been an attractive strategy because of its spatiotemporal control effect and minimal invasiveness, playing an important role in clinical application especially in the region of skin tumor treatment. PDT employs reactive oxygen species (ROS) production to achieve effective cancer therapy through a reaction between photosensitizers and O 2 presented in tumors triggered by laser irradiation. The delivery of photosensitizers is usually a pivotal point because of poor water solubility and insufficient tissue distribution of photosensitizers; thus, drug delivery systems are designed to expand the application of photosensitizers. Owing to the heterogeneous phenotypic characteristics and distance from the blood vessels of solid tumors, a hypoxic microenvironment is a typical feature of solid tumors, and oxygen consumption during PDT may aggravate hypoxia, which affects the application of PDT. PDT-induced tissue hypoxia is a result of vascular damage and photochemical oxygen consumption. Many studies have attempted to improve the O 2 supply in tumor treatment, for example, by suppressing glucose metabolism to retain adequate amounts of oxygen, 1 directly transporting O 2 via designed carriers to tumors 2 and catalyzing H 2 O 2 to produce O 2 via a catalyzer. 3,4 Besides, photodynamic therapy (PDT) combined with chemotherapy drugs that inhibit tumor hypoxia can also enhance the effectiveness and efficacy of anti-tumor therapy. For instance, Song et al developed amphiphilic nanoparticles by conjugating the photosensitive molecule Ce6 with PEG. These nanoparticles were utilized for the simultaneous delivery of cisplatin and metformin, a drug commonly used to treat diabetes. Metformin enhances sensitivity to tumor therapy by inhibiting tumor hypoxia induced by nuclear factor kpab signaling. This innovative approach has demonstrated the ability to effectively eradicate tumors both in vitro and in vivo through hypoxia-targeted multimodal therapy. 5 In addition, there is an alternative approach: the use of bioreducing drugs, such as telaprazine (TPZ), which can selectively induce the production of cytotoxic substances only in hypoxic conditions. TPZ specif -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology